Ampio Pharmaceuticals Inc AMPE

ASE: AMPE | ISIN: US03209T1097   14/11/2024
0,002 USD (0,00%)
(0,00%)   14/11/2024

2 juni 2022 · Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders · Persbericht

16 mei 2022 · Ampio Pharmaceuticals Reports First-Quarter Financial Results · Persbericht

16 mei 2022 · Ampio Independent Committee to Conduct Investigation · Persbericht

27 april 2022 · Ampio Pharmaceuticals, Inc. to Hold Conference Call · Persbericht

20 april 2022 · Ampio Provides Regulatory Update · Persbericht

29 maart 2022 · Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights · Persbericht

23 maart 2022 · Ampio Pharmaceuticals, Inc. to Hold Fourth Quarter 2021 Earnings and Business Update Call · Persbericht

9 maart 2022 · Ampio Pharmaceuticals to Participate at the 34th Annual Roth Conference · Persbericht

2 maart 2022 · Ampio Pharmaceuticals, Inc. Releases Positive Phase 3 Data Analysis for Ampion™ Targeting Severe Osteoarthritis of the Knee (OAK) · Persbericht

2 maart 2022 · Ampio Pharmaceuticals, Inc. to Host a Conference Call and Webinar · Persbericht

10 februari 2022 · Ampio Expands Board of Directors with Addition of Elizabeth Varki Jobes · Persbericht

6 januari 2022 · Ampio Pharmaceuticals Presents Corporate Overview at H.C. Wainwright Bioconnect Conference · Persbericht

16 december 2021 · Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders · Persbericht

13 december 2021 · Ampio Pharmaceuticals Announces Pricing Of $22.5 Million Registered Direct Offering · Persbericht

29 november 2021 · Ampio Pharmaceuticals to Host Business Update Call with Chairman and CEO Mike Martino on Wednesday, Dec. 1 · Persbericht

23 november 2021 · Ampio Pharmaceuticals Announces Shareholder / Business Update Call with its CEO & Chairman, Michael Martino · Persbericht

22 november 2021 · Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave · Persbericht

10 november 2021 · Ampio Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides Business Update · Persbericht

28 oktober 2021 · Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Business Update · Persbericht

13 oktober 2021 · Ampio Pharmaceuticals Strengthens Management Team and Board of Directors · Persbericht

Mijn selecties